0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

BILE SALT HEMOLYSIS IN NEW-BORN INFANTS AND ITS INHIBITION BY THE BLOOD SERUM

HEYWORTH N. SANFORD, M.D.; MARIAN M. CRANE, M.D.; ELEANOR I. LESLIE, M.D.
Am J Dis Child. 1930;40(5):1039-1044. doi:10.1001/archpedi.1930.01940050101012.
Text Size: A A A
Published online

Red blood cells are hemolyzed by various agents, such as saponin,1 cobra venom2 and mushroom toxins,3 both in vivo and in vitro. The blood serum has the power of protecting the red cells against greater concentrations of these agents than the cells can withstand alone. Bile salts have the property of hemolyzing red blood cells, and the red cells are protected against such hemolysis by their blood serum.4 Of all the various hemolytic agents, the bile salts are the most interesting from a clinical point of view because of the question as to whether or not bile salts existing in the blood stream as the result of hepatic obstruction may cause hemolysis. Ponder has contributed an immense amount of painstaking work on this phenomenon.

Donnelly and Mitchell5 found that the degree of the hemolyzing power of bile salts for normal red blood cells, as well

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();